Ubymo SPRL
Dissolution volontaire – liquidationThe score of Ubymo shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2018
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ubymo's annual accounts
Filed annual accounts
- Year ended 30 Jun 2018filed on 05 Feb 2019
- Year ended 30 Jun 2015filed on 29 Jan 2016
- Year ended 30 Jun 2014filed on 23 Dec 2014
- Year ended 30 Jun 2013filed on 19 Dec 2013
- Year ended 30 Jun 2012filed on 17 Dec 2012
Ubymo's financial analysis
- Solvency41.2%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ubymo
Ubymo's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.280.944
- VAT number
- BE0459280944
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 20 Nov 1996
- Registered office
- 9220 Hamme (Vl.)
- Latest accounts
- 2018 · filed on 05 Feb 2019
- Activity
- Manufacture of basic pharmaceutical products (NACE 2110001)
Ubymo (SPRL) has been based in Hamme (Vl.) since 1996, active in: manufacture of basic pharmaceutical products. For 2018, it reports a net loss of 5,636 € and equity of 18,878 €; its revenue is not published. Its solvency stands at 41.2%, below the median of its sector (56.0%).
Companies similar to Ubymo
Same activity (NACE code), registered office in the same province, closest balance-sheet size.
- RPO NucleoGenesis Manufacture of basic pharmaceutical products Ghent · balance sheet 107,514 €
- Tulipa Grafische Communicatie Manufacture of basic pharmaceutical products Ninove · balance sheet 119,693 €
- Studelco Manufacture of basic pharmaceutical products Geraardsbergen · balance sheet 17,230 €
- E.C.T. VAN Beersel Manufacture of basic pharmaceutical products Ghent · balance sheet 145,543 €
- Klima+ Service Manufacture of basic pharmaceutical products Nazareth-De Pinte · balance sheet 151,490 €
- Amalus Therapeutics Manufacture of basic pharmaceutical products Ghent · balance sheet 160,051 €
- Mayaku Pharmaceutical Development Manufacture of basic pharmaceutical products Ghent · balance sheet 170,483 €
- M.D.C.T. Benelux Manufacture of basic pharmaceutical products Deinze · balance sheet 184,719 €
Frequently asked questions about Ubymo
What is the revenue of Ubymo?
Ubymo files its accounts in a format where revenue is optional: it is not published for 2018.
What is the VAT number of Ubymo?
In Belgium, the VAT number is the company number prefixed with BE: BE0459280944 for Ubymo, if the company is VAT-registered. Its company number (CBE) is 0459.280.944.
Where is the registered office of Ubymo?
According to the CBE register, the registered office of Ubymo is in 9220 Hamme (Vl.).
What is the equity of Ubymo?
At the close of the 2018 financial year, the equity of Ubymo amounts to 18,878 €, a solvency of 41.2% of total assets.
Who manages Ubymo?
The register lists 1 active mandates at Ubymo. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ubymo
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →